[{"ID":"23692_33-2022_NCT04731493","TOPIC_YEAR":2022,"RESPONSE":"# INCLUSION CRITERIA\n\n* Patient aged between 7 and 25 years old with Marfan Syndrome or related according to Ghent criteria\n\nThe patient is 20 years old, which is within the inclusion criteria age range of 7 to 25 years old.\n\n* Patient has Marfan Syndrome, which is related to Ghent criteria\n\nThe patient has been diagnosed with Marfan Syndrome, which meets the inclusion criteria.\n\n# EXCLUSION CRITERIA\n\n* Inability of the patient to understand the content of the TEP sessions or the questionnaire about quality of life (non-French speaking, severe intellectual disability)\n\nThe patient does not have any intellectual disability or inability to understand the content of the TEP sessions or the questionnaire about quality of life, so this exclusion criterion does not apply.\n\n* Patient who has already participated in a TEP session for his pathology\n\nThe patient has not participated in any TEP sessions for his pathology, so this exclusion criterion does not apply.\n\nTherefore, the patient is eligible for the clinical trial.","PROBA":0.9446257532},{"ID":"35650_75-2021_NCT03421899","TOPIC_YEAR":2021,"RESPONSE":"# A: eligible","PROBA":0.7291657217},{"ID":"6999_15-2021_NCT03949933","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have a history of pancreatic cancer?\n\nNo, the patient does not have a history of pancreatic cancer.\n\n#2: Does the patient have a current diagnosis of pancreatic cancer?\n\nYes, the patient has a current diagnosis of pancreatic cancer based on the biopsy results.\n\n#3: Does the patient meet the inclusion criteria for the clinical trial?\n\nYes, the patient meets the inclusion criteria for the clinical trial because they have a histologically confirmed diagnosis of pancreatic cancer, and they have not received previous radiation therapy to the abdomen or radioactive particle implantation.\n\n#4: Does the patient meet the exclusion criteria for the clinical trial?\n\nNo, the patient does not meet any of the exclusion criteria for the clinical trial.\n\nTherefore, the patient is eligible for the clinical trial.","PROBA":0.9360553071},{"ID":"30719_65-2021_NCT02166372","TOPIC_YEAR":2021,"RESPONSE":"#C: irrelevant","PROBA":0.5054597923},{"ID":"30853_65-2021_NCT03394313","TOPIC_YEAR":2021,"RESPONSE":"# Type 1 diabetes vs. type 2 diabetes\n\nType 1 diabetes and type 2 diabetes are two different conditions. Type 1 diabetes is an autoimmune disease where the body's immune system attacks the cells in the pancreas that produce insulin, resulting in a complete deficiency of insulin production. Type 2 diabetes, on the other hand, is caused by insulin resistance, where the body's cells become less responsive to insulin, leading to high blood sugar levels.\n\n# Patient's condition\n\nThe patient has type 1 diabetes, which is not the same as type 2 diabetes. Therefore, the patient is not eligible for the clinical trial. The clinical trial is only for patients with type 2 diabetes and cardiovascular disease.","PROBA":0.937303253},{"ID":"14011_30-2021_NCT01358136","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have a thyroid disease?\nB: excluded\n\nThe patient has Hashimoto's thyroiditis, which is a thyroid disease.\n\n#2: Is the patient going to undergo hemithyroidectomy for nontoxic goiter?\nC: irrelevant\n\nThe patient is not going to undergo hemithyroidectomy, so they do not meet the inclusion criteria for the clinical trial.","PROBA":0.911624756},{"ID":"33428_71-2021_NCT00464984","TOPIC_YEAR":2021,"RESPONSE":"# A: eligible","PROBA":0.6878310232},{"ID":"35421_75-2021_NCT01225263","TOPIC_YEAR":2021,"RESPONSE":"#C: irrelevant","PROBA":0.6383908975},{"ID":"35461_75-2021_NCT01580787","TOPIC_YEAR":2021,"RESPONSE":"#1. Does the patient have Parkinson's disease? Yes.\n#2. Is the patient on stages 1 and 2,5 of Hoehn e Yahr? Yes.\n#3. Does the patient have any exclusion criteria? No.\n\nTherefore, the patient is eligible for the clinical trial.","PROBA":0.9028664662},{"ID":"17012_36-2021_NCT01252875","TOPIC_YEAR":2021,"RESPONSE":"#1. Is the patient's condition related to the trial's topic?\n\nNo, the patient's condition is not related to the trial's topic. The trial is focused on stroke and TIA, while the patient's condition is related to weight concerns and body shape dissatisfaction.\n\n#2. Is the patient eligible based on age?\n\nYes, the patient is eligible based on age. The trial is open to patients aged 18 years or older, and the patient is 32 years old.\n\n#3. Does the patient have any exclusion criteria?\n\nNo, the patient does not have any exclusion criteria based on the information provided.\n\nTherefore, the patient is not eligible for the clinical trial.","PROBA":0.9142435809},{"ID":"5533_12-2021_NCT04382612","TOPIC_YEAR":2021,"RESPONSE":"#C: irrelevant","PROBA":0.5652065712},{"ID":"14217_30-2021_NCT03862755","TOPIC_YEAR":2021,"RESPONSE":"#1: Is the patient a lung surgical patient? No.\n\n#2: Was the patient sent to the thoracic postoperative intensive care unit (ICU) ward right after surgery and stayed there for at least 24 hours? No.\n\n#3: Does the patient have any history of inferior vena filter and anti-coagulation treatment? No.\n\nTherefore, the patient is excluded from the clinical trial. C: irrelevant","PROBA":0.9071550889},{"ID":"35280_75-2021_NCT00001643","TOPIC_YEAR":2021,"RESPONSE":"#1. Does the patient have Parkinson's disease? Yes.\n\n#2. Is the patient over 18 years old? Yes.\n\n#3. Does the patient have a family history of Parkinson's disease? Not specified.\n\n#4. Is the patient willing to participate in the study? Not specified.\n\nBased on the information provided, the patient is potentially eligible for the clinical trial, but further evaluation is needed to determine their eligibility.","PROBA":0.8860163674},{"ID":"14169_30-2021_NCT03334955","TOPIC_YEAR":2021,"RESPONSE":"#1: Age\nThe patient is 33 years old, which is within the inclusion criteria of 20 to 34 years old.\n\n#2: BMI\nThe patient has a BMI of 31, which is within the inclusion criteria of 18 to 25 kg\/m2.\n\n#3: PCOS diagnosis\nThe patient has Hashimoto's thyroiditis, which is not within the inclusion criteria of PCOS.\n\n#4: Hysterosalpingography and husband semen analysis\nNot applicable, as the patient is not seeking fertility treatment.\n\n#5: Medical history and medications\nThe patient has a history of hypothyroidism and is currently taking Levothyroxine, but this is not excluded in the inclusion criteria.\n\nTherefore, the patient is not eligible for the clinical trial.","PROBA":0.9104680202},{"ID":"17418_36-2021_NCT04599803","TOPIC_YEAR":2021,"RESPONSE":"#1: Is the patient 18 years or older?\nB: excluded (the patient is 32 years old, which is not 18 years or older)\n\n#2: Does the patient own a smartphone with a data plan and be the primary user of the smartphone?\nB: excluded (the patient does not own a smartphone)\n\n#3: Does the patient have a high risk of OSA as determined by screening questionnaire?\nC: irrelevant (the patient's note does not mention anything about sleep apnea or OSA)\n\n#4: Is the patient willing and able to sign the informed consent form?\nB: excluded (the patient does not own a smartphone)\n\nTherefore, the patient is excluded from the clinical trial.","PROBA":0.9095766436},{"ID":"30761_65-2021_NCT02455011","TOPIC_YEAR":2021,"RESPONSE":"# Type 1 diabetes\n\nThe patient has type 1 diabetes, which is not type 2 diabetes. Therefore, the patient is not eligible for the clinical trial.","PROBA":0.8770266512},{"ID":"33904_71-2021_NCT04215380","TOPIC_YEAR":2021,"RESPONSE":"# Polycystic Ovary Syndrome (PCOS)\n\nC: irrelevant","PROBA":0.8749709529},{"ID":"35608_75-2021_NCT03001453","TOPIC_YEAR":2021,"RESPONSE":"#1. Does the patient have hip osteoarthritis? No.\n\n#2. Has the patient failed to improve with conservative measures? No.\n\n#3. Is the patient scheduled to undergo primary unilateral total hip replacement? No.\n\nTherefore, the patient is not eligible for the clinical trial. C: irrelevant.","PROBA":0.9243527748},{"ID":"5553_12-2021_NCT04653428","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have severe tricuspid regurgitation?\n\nNo, the patient does not have severe tricuspid regurgitation.\n\n#2: Is the patient undergoing interventional treatment for tricuspid regurgitation?\n\nNo, the patient is not undergoing interventional treatment for tricuspid regurgitation.\n\n#3: Is the patient at least 18 years old?\n\nYes, the patient is at least 18 years old.\n\nTherefore, the patient is not eligible for the clinical trial.","PROBA":0.9352400897},{"ID":"27487_40-2022_NCT00386308","TOPIC_YEAR":2022,"RESPONSE":"The patient is a woman with heavy menstrual bleeding, which meets the inclusion criterion of the study.\n\nThe patient is between 18 and 49 years old, which also meets the inclusion criterion.\n\nThe patient has a history of heavy menstrual bleeding, which is the primary inclusion criterion of the study.\n\nTherefore, the patient is eligible for the clinical trial.","PROBA":0.8929601769},{"ID":"35476_75-2021_NCT01767818","TOPIC_YEAR":2021,"RESPONSE":"The patient does not meet the inclusion criteria for the clinical trial because they do not have a diagnosis of idiopathic Parkinson's disease. The patient has been diagnosed with Parkinson's disease, but the clinical trial requires a diagnosis of idiopathic Parkinson's disease.\n\nTherefore, the patient is not eligible for the clinical trial.","PROBA":0.9163046598},{"ID":"6695_15-2021_NCT01315548","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have a suspicion of a solid pancreatic tumor mass?\nB: Excluded","PROBA":0.7966103242},{"ID":"17155_36-2021_NCT02542735","TOPIC_YEAR":2021,"RESPONSE":"#1. Is the patient part of the general population?\nB: excluded","PROBA":0.783654809},{"ID":"16986_36-2021_NCT01046032","TOPIC_YEAR":2021,"RESPONSE":"#C: irrelevant","PROBA":0.6465142642},{"ID":"33905_71-2021_NCT04218045","TOPIC_YEAR":2021,"RESPONSE":"# BMI \u2265 40 kg\/m2\nBMI = 41.54 (calculated from 113 kg and 165 cm)\nBMI \u2265 40 kg\/m2: True\n\n# Age \u2265 18 and < 60\nAge: 34 (true)\n\n# Failure to achieve adequate and consistent weight loss for at least one year while being followed up by a dietitian\nNot specified in the patient note.\n\nBased on the criteria, the patient is eligible for the clinical trial.","PROBA":0.9092293506},{"ID":"27584_40-2022_NCT01051544","TOPIC_YEAR":2022,"RESPONSE":"#1: Does the patient have severe hemophilia A?\n\nNo, the patient does not have severe hemophilia A.\n\n#2: Is the patient male?\n\nNo, the patient is female.\n\n#3: Does the patient have a high responder inhibitor?\n\nNo, the patient does not have an inhibitor.\n\n#4: Is the patient at least 7 years old?\n\nYes, the patient is at least 7 years old.\n\n#5: Does the patient have any risk factors for ITI failure?\n\nNo, the patient does not have any risk factors for ITI failure.\n\n#6: Is the patient willing and able to participate in the study?\n\nNo, the patient is not eligible for the study.\n\nTherefore, the patient is not eligible for the clinical trial.","PROBA":0.9375974699},{"ID":"6723_15-2021_NCT01531712","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have pancreatic adenocarcinoma?\nB: excluded","PROBA":0.7838790587},{"ID":"7014_15-2021_NCT04085055","TOPIC_YEAR":2021,"RESPONSE":"#1: Is the patient \u2265 18 years old?\nB: excluded","PROBA":0.7420030123},{"ID":"30501_65-2021_NCT00774566","TOPIC_YEAR":2021,"RESPONSE":"#1. Does the patient have paroxysmal PAF?\nNo, the patient does not have paroxysmal PAF.\n\n#2. Is the patient at least 18 years old?\nYes, the patient is 25 years old, which is greater than or equal to 18 years old.\n\n#3. Has the patient had a documented failure of at least one AAD, including beta-blockers?\nNo, the patient does not have a documented failure of at least one AAD, including beta-blockers.\n\nTherefore, the patient is not eligible for the clinical trial.","PROBA":0.9272579709},{"ID":"25426_53-2021_NCT04524832","TOPIC_YEAR":2021,"RESPONSE":"#1: Age\nThe patient is 34 years old, which is within the age range of 18-64 years for the clinical trial. So, the patient is eligible based on age.\n\n#2: BMI\nThe patient has a BMI of 23, which is within the range of 21.0-29.9 kg\/m^2 for the clinical trial. So, the patient is eligible based on BMI.\n\n#3: Medical History\nThe patient has no history of major surgical procedures involving the stomach, and there is no history of pancreatitis. The patient is not pregnant, breast-feeding, or planning to become pregnant during the study period. Therefore, the patient is eligible based on medical history.\n\n#4: Physical Examination and Laboratory Tests\nThe patient has no clinically significant gastrointestinal disorders or symptoms of gastrointestinal disorders potentially affecting absorption of drugs or nutrients, as judged by the investigator. The patient's laboratory study is remarkable for Vit D: 14ng\/ml and otherwise healthy. Therefore, the patient is eligible based on physical examination and laboratory tests.\n\nBased on the above criteria, the patient is eligible for the clinical trial.","PROBA":0.9429192706},{"ID":"33692_71-2021_NCT02538328","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have obesity?\nA: Yes, the patient has obesity, as her BMI is 41.5.\n\n#2: Is the patient's BMI over 40 kg\/m^2?\nA: Yes, the patient's BMI is over 40 kg\/m^2, so she meets the inclusion criteria for the clinical trial.\n\nTherefore, the patient is eligible for the clinical trial.","PROBA":0.9262746885},{"ID":"14025_30-2021_NCT01513928","TOPIC_YEAR":2021,"RESPONSE":"#1: Is the patient male or female?\nB: female\n\n#2: Is the patient between the ages of 21 and 55 years old?\nB: yes\n\n#3: Does the patient have any clinically significant hematological, renal, endocrine, pulmonary, gastrointestinal, cardiovascular, hepatic, psychiatric, neurologic, or allergic disease?\nB: no\n\n#4: Does the patient have any condition possibly affecting drug absorption?\nB: no\n\n#5: Does the patient have a positive urine drug screen?\nB: no\n\nTherefore, the patient is eligible for the clinical trial.","PROBA":0.9457585963},{"ID":"17442_36-2021_NCT04781426","TOPIC_YEAR":2021,"RESPONSE":"#1. Is the patient HIV-negative? Yes.\n#2. No suspicion of acute HIV infection? Yes.\n#3. Substantial risk of HIV infection? No.\n#4. Creatinine clearance is more than 30 ml\/min? Not relevant for the clinical trial.\n#5. Willingness to use PrEP as prescribed, including periodic HIV testing? Not relevant for the clinical trial.\n#6. Willingness to sign informed consent? Not relevant for the clinical trial.\n\nTherefore, the patient is not eligible for the clinical trial. C: irrelevant.","PROBA":0.9354701499},{"ID":"27767_40-2022_NCT02472665","TOPIC_YEAR":2022,"RESPONSE":"#1: Does the patient have a diagnosis of Von Willebrand Disease?\n\nNo, the patient does not have a diagnosis of Von Willebrand Disease.\n\n#2: Is the patient experiencing prolonged oral bleeding?\n\nYes, the patient is experiencing prolonged oral bleeding.\n\n#3: Is the patient taking desmopressin (DDAVP)?\n\nYes, the patient is taking desmopressin (DDAVP).\n\n#4: Does the patient have a history of heavy menstrual cycles?\n\nYes, the patient has a history of heavy menstrual cycles.\n\n#5: Is the patient's mother and grandmother also diagnosed with Von Willebrand Disease?\n\nNo, the patient's mother and grandmother are not diagnosed with Von Willebrand Disease.\n\nBased on the information provided, the patient is not eligible for the clinical trial for Von Willebrand Disease. The patient's symptoms are more consistent with heavy menstrual bleeding, which is not the focus of the clinical trial.","PROBA":0.9250236413},{"ID":"5392_12-2021_NCT02581514","TOPIC_YEAR":2021,"RESPONSE":"#1. Does the patient have hypereosinophilia?\n\nNo, the patient does not have hypereosinophilia. The patient has Marfan's syndrome and known severe mitral valve prolapse with regurgitation, but there is no mention of hypereosinophilia.\n\n#2. Does the patient have organ damage with infiltration proven by pathological examination?\n\nNo, there is no mention of organ damage with infiltration proven by pathological examination.\n\n#3. Has the patient been symptomatic for at least six months?\n\nNo, the patient is prepared to undergo mitral valve repair\/replacement surgery, but there is no mention of the patient having been symptomatic for at least six months.\n\n#4. Is the patient affiliated or beneficiary of a social security system?\n\nYes, the patient is affiliated or beneficiary of a social security system.\n\n#5. Has the patient signed the informed consent?\n\nYes, the patient has signed the informed consent.\n\nBased on the above, the patient is not eligible for the clinical trial. The patient does not have hypereosinophilia, and the patient does not meet the criteria for organ damage or symptom duration. Additionally, the patient is not eligible for the clinical trial because the patient has a known medical condition (Marfan's syndrome and severe mitral valve prolapse) that is not related to eosinophilia.","PROBA":0.9434877113},{"ID":"17258_36-2021_NCT03279432","TOPIC_YEAR":2021,"RESPONSE":"#1. Is the patient obese? Yes.\n#2. Does the patient have a BMI of 41.54, which is considered obese? Yes.\n#3. Is the patient complaining of sleep apnea? Yes.\n#4. Does the patient have a history of prior pregnancies? No.\n#5. Is the patient a high-school teacher? Yes.\n\nBased on the criteria for the clinical trial, the patient is eligible for the study.","PROBA":0.8773363743},{"ID":"16951_36-2021_NCT00770276","TOPIC_YEAR":2021,"RESPONSE":"The patient is a 32-year-old obese woman who is concerned about her weight and has a BMI of 41.54, which falls within the WHO III degree of obesity. Therefore, she meets the inclusion criteria for the clinical trial.\n\nThe patient does not have any exclusion criteria, such as pregnancy or acute vascular event within the last 3 months, that would prevent her from participating in the study.\n\nTherefore, the patient is eligible for the Mannheim Obesity Study.","PROBA":0.8852283544},{"ID":"16940_36-2021_NCT00696111","TOPIC_YEAR":2021,"RESPONSE":"#B: excluded","PROBA":0.6683634759},{"ID":"35602_75-2021_NCT02930512","TOPIC_YEAR":2021,"RESPONSE":"#1. Does the patient have idiopathic Parkinson's disease?\nB: excluded","PROBA":0.7831333165},{"ID":"11827_17-2022_NCT03264885","TOPIC_YEAR":2022,"RESPONSE":"#1: Does the patient have visual impairment?\nB: excluded","PROBA":0.7476633752},{"ID":"27766_40-2022_NCT02466789","TOPIC_YEAR":2022,"RESPONSE":"#1. Does the patient have a bleeding disorder? No.\n#2. Does the patient have a low level of von Willebrand factor (VWF)? No.\n#3. Is the patient being evaluated for the diagnosis of VWD? No.\n\nTherefore, the patient is not eligible for the clinical trial. C: irrelevant","PROBA":0.8483185961},{"ID":"33677_71-2021_NCT02441530","TOPIC_YEAR":2021,"RESPONSE":"#1. Does the patient have a uterus?\n\nC: irrelevant","PROBA":0.6726973914},{"ID":"35813_75-2021_NCT04717271","TOPIC_YEAR":2021,"RESPONSE":"# A: eligible","PROBA":0.718405941},{"ID":"35670_75-2021_NCT03587168","TOPIC_YEAR":2021,"RESPONSE":"# A: eligible","PROBA":0.6608989667},{"ID":"17353_36-2021_NCT04106661","TOPIC_YEAR":2021,"RESPONSE":"#B: excluded","PROBA":0.6323821513},{"ID":"6663_15-2021_NCT01015820","TOPIC_YEAR":2021,"RESPONSE":"#1: Age\nThe patient is 70 years old, which is within the age range of 18-65 years for the clinical trial. Therefore, the patient meets the age criterion.\n\n#2: Diagnosis\nThe patient has been diagnosed with pancreatic adenocarcinoma, which is a type of cancer that is included in the clinical trial. Therefore, the patient meets the diagnosis criterion.\n\n#3: Scheduled for EGD with upper EUS\nThe patient is scheduled for EGD with upper EUS, which is one of the inclusion criteria for the clinical trial. Therefore, the patient meets this criterion.\n\n#4: No known familial disorder or significant family history of pancreatic cancer\nThe patient does not have a known familial disorder or significant family history of pancreatic cancer, which is one of the exclusion criteria for the clinical trial. Therefore, the patient meets this criterion.\n\n#5: No premalignant lesions\nThe patient does not have premalignant lesions, which is one of the exclusion criteria for the clinical trial. Therefore, the patient meets this criterion.\n\n#6: No active visible inflammation\/ulcer in the stomach or duodenum\nThe patient does not have active visible inflammation\/ulcer in the stomach or duodenum, which is one of the exclusion criteria for the clinical trial. Therefore, the patient meets this criterion.\n\nBased on the information provided, the patient is eligible for the clinical trial.","PROBA":0.9604448884},{"ID":"14268_30-2021_NCT04433936","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have thyroid gland dysfunction?\n\nYes, the patient has been diagnosed with Hashimoto's thyroiditis, which is a type of thyroid gland dysfunction.\n\n#2: Is the patient in the study group (patients with TGD) or the control group (healthy subjects without known personal or family history of thyroid disease)?\n\nB: excluded\n\nThe patient is excluded from the study because they have a known history of thyroid disease (Hashimoto's thyroiditis). Healthy subjects without any known personal or family history of thyroid disease are required for the control group.","PROBA":0.9223334588},{"ID":"27622_40-2022_NCT01384331","TOPIC_YEAR":2022,"RESPONSE":"#1. Age: 23 years old, which is within the age range of 18-45 years.\n\n#2. Using the subdermal progestogen-only contraceptive implant: No, the patient is not using the subdermal progestogen-only contraceptive implant.\n\n#3. Experiencing frequent or prolonged vaginal bleeding: Yes, the patient is experiencing prolonged oral bleeding after a tooth extraction.\n\n#4. Willing to keep a menstrual diary for 6 months: Not applicable, as the patient is not experiencing menstrual bleeding due to her use of the subdermal progestogen-only contraceptive implant.\n\nBased on the criteria, the patient is not eligible for the clinical trial.","PROBA":0.9230766529},{"ID":"7044_15-2021_NCT04325867","TOPIC_YEAR":2021,"RESPONSE":"#1. Does the patient have a known cardiovascular disease?\n\nNo, the patient does not have a known cardiovascular disease.\n\n#2. Does the patient have any of the following conditions: all spectrum of coronary syndromes (chronic to acute) +\/- known coronary angioplasties; treated arterial hypertension; known congestive heart failure?\n\nNo, the patient does not have any of these conditions.\n\n#3. Is the patient isolated\/quarantined due to COVID-19 pandemic?\n\nYes, the patient is isolated\/quarantined due to COVID-19 pandemic.\n\nBased on the above, the patient is not eligible for the clinical trial.","PROBA":0.9486544423},{"ID":"16902_36-2021_NCT00417547","TOPIC_YEAR":2021,"RESPONSE":"#1. Is the patient a woman? Yes.\n\n#2. Does the patient practice Islamic veil? No.\n\n#3. Is the patient non-complete IVP or Inconsiderate to IVP? No.\n\n#4. Is the patient eligible for the exclusion criteria? No (no overt signs of Anorexia Nervosa or Bulimia Nervosa)\n\n#5. Is the patient eligible for the clinical trial? No.\n\nTherefore, the patient is not eligible for the clinical trial.","PROBA":0.9093943387}]
